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The major acid-soluble protein components of the mus-
sel Mytilus galloprovincialis sperm chromatin consist of 
the protamine-like proteins PL-II, PL-III and PL-IV, an 
intermediate group of sperm nuclear basic proteins be-
tween histones and protamines. The aim of this study 
was to investigate the bactericidal activity of these pro-
teins since, to date, there are reports on bactericidal ac-
tivity of protamines and histones, but not on protamine-
like proteins. We tested the bactericidal activity of these 
proteins against Gram-positive bacteria: Enterococcus 
faecalis and two different strains of Staphylococcus au-
reus, as well as Gram-negative bacteria: Proteus mirabilis, 
Proteus vulgaris, Pseudomonas aeruginosa, Salmonella ty-
phmurium, Enterobacter aerogenes, Enterobacter cloacae, 
and Escherichia coli. Clinical isolates of the same bacterial 
species were also used to compare their sensitivity to 
these proteins. The results show that Mytilus galloprovin-
cialis protamine-like proteins exhibited bactericidal activ-
ity against all bacterial strains tested with different mini-
mum bactericidal concentration values, ranging from 
15.7 to 250 µg/mL. Furthermore, these proteins were ac-
tive against some bacterial strains tested that are resist-
ant to conventional antibiotics. These proteins showed 
very low toxicity as judged by red blood cell lysis and 
viability MTT assays and seem to act both at the mem-
brane level and within the bacterial cell. We also tested 
the bactericidal activity of the product obtained from an 
in vitro model of gastrointestinal digestion of protamine-
like proteins on a Gram-positive and a Gram-negative 
strain, and obtained the same results with respect to un-
digested protamine-like proteins on the Gram-positive 
bacterium. These results provide the first evidence of 
bactericidal activity of protamine-like-proteins.
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INTRODUCTION
Antibiotic resistant bacteria represent an important 
threat to public health that requires a prompt develop-
ment of new antibiotics to replace those that become 
ineffective. Much work has been devoted to developing 
highly efficient compounds that are also less susceptible 
to the development of resistance by bacteria. Over the 
past two decades it has been necessary to search for 
natural products as sources of new bactericidal agents 
(Tepe et al., 2004).
Peptides and proteins with bactericidal activity are rec-
ognized as important components of the innate defense 
system and are produced from both prokaryotes and eu-
karyotes, including fungi, plants (Basile et al., 2017; Pis-
copo et al., 2018a), invertebrates and vertebrates (Tepe et 
al., 2004; Wang, 2014).
Several bioactive compounds have been identified in 
marine organisms which represent a large reservoir for 
pharmacologically potent and active drugs that evolved to 
deal with extremely difficult, competitive, and aggressive 
constraints of the environment in which they live (Piscopo 
et al., 2018b; Maresca et al., 2018), and which are very dif-
ferent compared to those in terrestrial environments (Con-
te et al., 2017). Cationic compounds have been demon-
strated as potential candidates for new bactericidal agents 
since they have a low potential for the development of re-
sistance (Carmona-Ribeiro et al., 2013). Moreover, histones 
for example have displayed potent bactericidal activity in 
many organisms as both, intact proteins or cleaved pep-
tides (Poirier et al., 2014; Rose-Martel et al., 2014). There is 
also evidence in the literature about the bactericidal prop-
erties of protamines, such as clupeine and salmine, herring 
and salmon protamines, that exhibit activity against some 
pathogenic Gram-positive and Gram-negative bacteria, re-
spectively (Potter et al., 2005; Miura et al., 2010). However, 
nothing has been presented to date on the bactericidal ac-
tivity of protamine-like proteins (PL-proteins), which are 
one of the three types of Sperm Nuclear Basic Proteins 
(SNBPs) and represent a structurally and functionally in-
termediate group of proteins between the histone (H) and 
protamine (P) type (Ausió, 1999). These proteins are re-
lated to histone H1 and are arginine-and lysine-rich (Fio-
retti et al., 2012; Piscopo et al., 2010). They were first de-
scribed in bivalve mollusks but later have been also found 
in echinoderms, tunicates, and vertebrates (Ausió, 1995; 
Eirin-Lo´pez et al., 2006). Two main PL-protein subtypes 
exist: those referred to as PL-I, whose structure consists 
of a winged-helix domain (WHD), as well as Branchiosto-
ma’s PL (Eirin-Lo´pez et al., 2006) and Mytilus PL-III that 
lack this domain (Eirin-Lo´pez et al., 2006). Low molecu-
lar weight PL-proteins lacking the WHD have only been 
described in the invertebrate organisms (Eirin-Lo´pez et 
al., 2008). In the sperm chromatin of M. galloprovincialis, 
Vol. 65, No 4/2018
585–594
https://doi.org/10.18388/abp.2018_2638
586           2018R. Notariale and others
which is considered to be a Mediterranean derivative of 
M. edulis (Barsotti et al., 1968), three types of proteins are 
associated with the sperm DNA: (1) the PL-proteins: PL-
II, PL-III, and PL-IV (76% of the overall nuclear protein 
composition); (2) the four core histones (20%); and (3) 
three non-histone proteins tightly bound to DNA (4%) 
(Ausió, 1986; Lewis & Ausió, 2002). Sperm nuclear pro-
tein composition has been thoroughly studied and shown 
to be extremely conserved throughout all Mytilus species 
that have been studied so far and which include: gallopro-
vincialis, edulis, califotrnianuus and trossulus (Ausió & Subirana, 
1982; Ausió & McParland, 1989; Mogensen et al., 1991; 
Rocchini et al., 1995). The three PL-proteins were previ-
ously known as: φ2B (PL-II), φ1(PL-III) and φ3 (PL-IV) 
(Ausió et al., 1982).
The percentage of the three individual PL-proteins in 
reference to overall total nuclear proteins is the follow-
ing: PL-III (50%), PL-II (20%) and PL-IV (6%) (Lewis 
and Ausió, 2002), while their molecular weights are 11.3 
kDa, 14 kDa, and 6.5 kDa, respectively.
M. galloprovincialis PL-II (14 kDa) contains a conserved 
globular core of 84 amino acid residues that has a high 
structural similarity to histone H1 WHD (Carlos et al., 
1993a). PL-IV protein (6.5 kDa) has a highly lysine-rich 
composition similar to that of the somatic histone H1 
C-terminal tail (Phelan et al., 1974). PL-III protein (11.3 
kDa), rich in both lysine and arginine, is intermediate 
between histones and protamines and, like protamines, 
lacks any specific secondary structure in vitro (Rocchini 
et al., 1995; Carlos et al., 1993a) and possesses sequence 
similarity with the N-terminal region of Spisula PL-I 
(Lewis et al., 2004). PL-II and PL-IV are derived from a 
post-translational cleavage of a common (PL-I) precur-
sor (Carlos et al.,1993b) whereas PL-III derives from an 
independent gene product (Lewis et al., 2002).
In this study, we investigated the bactericidal activity on 
different Gram-positive and Gram-negative bacteria of in-
dividually purified M. galloprovincialis PL-proteins, as well as 
that of the crude extract containing the three PL-proteins, 
obtained by extraction with 5% perchloric acid (PCA) 
from spermatozoa. Furthermore, we evaluated the toxic-
ity of these proteins and investigated their action site in 
bacterial cells. Finally, we analyzed the bactericidal activity 
of the product obtained from an in vitro model of gastro-
intestinal digestion of the crude extract of these proteins.
MATERIALS AND METHODS
Ethics Statement. The research described herein was 
performed on the marine invertebrate M. galloprovincialis 
(Lamarck, 1819), which is not protected by any envi-
ronmental agency in Italy. This study was conducted in 
strict accordance with European (Directive 2010/63) and 
Italian (Decreto Legislativo n. 116/1992) legislation on 
the care and use of animals for scientific purposes.
Materials and specimens. Chemical reagents were 
obtained from Sigma, Difco and Diagnostic Pasteur 
(USA). Electrophoresis reagents and apparatuses were 
from Biorad. Adult male M. galloprovincialis mussels were 
kindly provided by the Cooperative Institute for Region-
al Development and Implementation of mussels (EU-
ROFISH NAPOLI S.R.L.) Baia, in Naples. Whole blood 
was taken with informed consent from healthy volun-
teers of Campania University “Luigi Vanvitelli”, Naples, 
Italy, along with the author Rosaria Notariale.
Red Blood Cells and Lymphocytes’ purification. 
Red Blood Cells and Lymphocytes were purified by Fi-
coll-Paque density gradient centrifugation.
Sperm collection, extraction and purification of 
M. galloprovincialis PL-proteins. Spermatozoa collec-
tion from M. galloprovincialis mussels was performed as 
previously described (Piscopo et al., 2018b). The crude 
extract containing the three PL-proteins from M. gallo-
provincialis spermatozoa was obtained by extraction with 
5% PCA as previously described (Piscopo et al., 2018c), 
starting from a pool of spermatozoa collected from 20 
Mytilus galloprovincialis specimens. M. galloprovincialis PL-II 
and PL-III were fractionated by ionic exchange resin cel-
lulose Whatman CM52 as previously described (Vassalli 
et al., 2015). The lyophilized crude extracts containing 
the three PL-proteins and the single purified PL-proteins 
were stored at –80° C.
Electrophoretic analyses on polyacrylamide gels 
of M. galloprovincialis PL-proteins and of their in 
vitro model of gastrointestinal digestion product. 
PL-protein samples were analyzed both, by Acetic Acid 
Urea-Polyacrylamide Gels Electrophoresis (AU-PAGE) 
and by SDS-PAGE, while the in vitro model of gastro-
intestinal digestion product of PL-proteins was analyzed 
only by SDS-PAGE.
AU-PAGE was performed as previously described 
(Salvati et al., 2008; Piscopo et al., 2018d), using 9.0% 
(w/v) acrylamide (acrylamide:bisacrylamide 30:0.8).
SDS-PAGE was performed with stacking gel at 5.0% 
(w/v) acrylamide (acrylamide/bis-acrylamide 30:0.15) and 
separating gel at 18.0% (w/v) acrylamide (acrylamide/
bis-acrylamide 30:0.15) as previously described by Pisco-
po and others (Piscopo et al., 2006).
Microorganisms. Bacterial strains from ATCC 
(Rockville, MD, USA) were used. They included the 
following Gram positive bacteria: Staphylococcus aureus 
(ATCC 13709 and ATCC 6738) and Enterococcus faecalis 
(ATCC 14428), and Gram negative bacteria: Proteus mi-
rabilis (ATCC 7002), Proteus vulgaris (ATCC 12454), Pseu-
domonas aeruginosa (ATCC 27853), Salmonella typhi (ATCC 
19430), Enterobacter aerogenes (ATCC 13048), Enterobacter 
cloacae (ATCC 10699), Klebsiella pneumoniae (ATCC 27736), 
and Escherichia coli (ATCC 8739). Clinical isolates (CI) of 
almost all of the above bacterial strains were also used 
to compare their sensitivity to M. galloprovincialis PL-pro-
teins. Bacterial clinical isolates were kindly provided by 
the Plant Pathology Department of the University Fed-
erico II, Naples, Italy.
All the bacterial strains from the ATCC and clinical 
isolate bacteria are shown in Table 1.
Bactericidal activity assays. For the bactericidal ac-
tivity we tested the crude extract containing all PL-pro-
teins, the purified single molecules (PL-II, PL-III and 
PL-IV) and the digest, i.e. the product of in vitro mod-
el of gastrointestinal digestion of the crude extract of 
PL-proteins. The crude extract containing all PL-proteins 
from spermatozoa was obtained by 5% perchloric acid 
extraction and is shown in Fig. 1. Bacterial strains were 
grown on Mueller Hinton (MH) agar plates (DIFCO) 
and suspended in Mueller Hinton (MH) broth (DIFCO). 
The minimum inhibitory concentration (MIC) values 
against bacterial species were performed by broth-dilu-
tion method (MH broth) as previously described (Basile 
et al., 1997). The bacterial broth culture was incubated at 
37±1°C until it achieved or exceeded the turbidity of the 
0.5 McFarland standard (usually two to six h) (Murray 
et al., 1995; Washington et al., 1972 ). Next, suspensions 
containing 106 cells/mL were prepared by diluting the 
previous broth culture at 1:100. Ten serial two-fold di-
lutions were made for the PL-protein concentrations and 
for the product of in vitro model of gastrointestinal diges-
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tion of the crude extract of these proteins in a range be-
tween 0.97–500 µg/mL in 0.05 M Tris buffer (pH 7.4).
For all bacterial strains, a control was made with only 
bacteria in MH broth without PL-proteins. MIC and 
MBC values of the crude extract containing the three 
PL-proteins, as obtained by extraction with 5% PCA, 
and of the purified single molecules (PL-II, PL-III and 
PL-IV), were determined for all the bacterial strains test-
ed, while MIC and MBC values of the digest were deter-
mined only for S. aureus (ATCC 6738) and E. coli (ATCC 
8739).
The bacterial suspensions were aerobically incubated 
for 18±2 h at 37°C. The MIC was defined as the lowest 
concentration able to inhibit any visible bacterial growth. 
Cultures containing only sterile physiological 0.05M Tris 
buffer (pH 7.4) which did not influence bacterial growth 
were used as controls.
The MIC values were also determined for tetracycline 
hydrochloride (Pharmacia, Milano), benzyl penicillin so-
dium (Cynamid, Catania) and cefotaxime sodium (Rous-
sel Pharma, Milano) in MH broth using standard meth-
ods. Following this, the bacterial cultures were plated on 
non-inhibitory solid media (Mueller Hinton agar) and in-
cubated at 37±1°C for 18±2 h to detect survival. MBC 
was then estimated as the lowest concentration of bacte-
ricidal molecule resulting in no growth. Each experiment 
was repeated three times.
Fluorescence microscopy. 5 mg/mL of the crude 
extract containing all PL-proteins in 100 mM HEPES 
(pH 7.4) were incubated with 7-diethylamino couma-
rin-3-carboxylic acid, succinimidyl ester (DEAC,SE 
Anaspec) at 1:3 molar ratio (PL-proteins: DEAC,SE) at 
room temperature for 24 h. DEAC,SE -PL-protein con-
jugate was added both to S. aureus (ATCC 6738) and 
E. coli (ATCC 8739), inoculated at a sub lethal concen-
tration (15 and 31.3 µg/mL, respectively), and incubated 
for 24 h at 37°C. Then, the cells were washed with cul-
ture medium to remove excess dyes and mounted on a 
glass slide. DEAC,SE-free dye was added both to S. au-
reus (ATCC 6738) and E. coli (ATCC 8739) inocula as a 
negative control. Bacteria were also stained with 4’,6-di-
amino-2-phenylindole (DAPI) in order to stain bacterial 
DNA. Images of the bacterial cells were obtained with 
a Nikon Eclipse E1000 microscope (Nikon Instruments 
Europe, Tokyo, Japan) with a magnification of 400x.
Measurement of nucleotide leakage. Nucleotide 
leakage from S. aureus (ATCC 6738) and E. coli (ATCC 
8739) was determined as follows: logarithmic phase bac-
Table 1. Evaluation of bacteriostatic activity of M. galloprovincialis PL–proteins
MIC 
μg/mL
MIC 
μg/mL
MIC 
μg/mL
MIC 
μg/mL
MIC 
μg/mL
MIC 
μg/mL
MIC 
μg/mL
Gram reaction Bacterial strains Crude extract PLII PLIII PIV CTAX PENG TET
+ S. aureus ATCC 6738 31.3±0.0 31.3±0.2 62.5±0.5 125±0.5 2±0.1 0.3±0.1 2±0.1
+ S. aureus ATCC 13709 15.7±0.3 15.7±0.1 31.3±0.1 31.3±0.2 2±0.1 0.03±0 2±0.1
+ S. aureus CI 31.3±0.2 31.3±0.2 62.5±0.3 31.3±0.2 R R R
+ E. faecalis ATCC 14428 31.3±0.1 62.5±0.5 62.5±0.1 62.5±0.5 R    8 ±0.2 2±0.1 
+ E. faecalis CI 62.5±0.5 62.5±0.3 125±0.5 125±0.3 R    R R
– P. vulgaris ATCC 12454 31.3± 0.1 62.5 ±0.5 125±0.5 125±0.3 2±0.1 4 ±.3 R
– P. vulgaris CI 62.5±0.1 62.5±0.2 125±0.3 250±0.5 32±0.3 R R
– P. mirabilis ATCC 7002 250±0.2 31.3±0.3 62.5±0.2 62.5±0.3 0.03±0 4 ±0.2 32±0.6 
– S. typhi ATCC 19430 7.8±0.1 15.7±0.2 31.3±0.2 31.3± 0.1 0.5±0.1 4 ±0.2 1±0.3 
– S. typhi CI 7.8±0.1 15.7±0.1 62.5±0.5 31.3± 0.1 1±0.1 2 ±0.1 1±0.1
– E. cloacae ATCC 10699 15.7±0.3 31.3±0.1 62.5±0.1 62.5±0.2 R 4 ±0.4 R
– E. cloacae CI 31.3±0,2 31.3±0.1 125±0.4 125±0.1 R R R
– E. aerogenes ATCC 13048 125±0.3 62.5±0.5 125±0.4 125±0.2 R 4 ±0.1 R
– E. aerogenes CI 250±0.1 125±0.5 125±0.5 250±0.5 R R R
– P. aeruginosa ATCC 27853 31.3±0.1 62.5±0.3 125±0.5 125±0.3 16 ±0.3 R 32±0.1
– P. aeruginosa CI 62.5±0.5 125±0.3 250±0.5 125±0.4 32±0.4 R R
– E. coli ATCC 8739 62.5±0.3 62.5± 0.1 62.5±0.3 125±0.3 4 ±0.1 2±0.1 8±0.1 
Minimum Inhibitory Concentration (MIC) values (µg/mL) of the crude extract containing the three M. galloprovincialis PL–proteins and those of the 
purified PL–II, PL–III, and PL–IV for bacterial strains analyzed. CTAX, Cefotaxime; PENG, Benzyl Penicillin Sodium; TET, Tetracycline; CI, Clinically Iso-
lated. R, Resistant. Values represent mean ±S.D. (n=3).
Figure 1. Analysis of PL-proteins from M. galloprovincialis
(A) lanes 1, 2, and 3 (crude extract containing PL-proteins, 5, 10 
and 20 µg, respectively); lanes 4, 5 (PL-II, 5 and 10 µg respective-
ly), lanes 6 and 7 (PL-III, 5 and 10 µg respectively). (B) lanes 1 and 
2 (PL-IV, 6 and 3 µg respectively), lane 3 (crude extract containing 
PL-proteins, 10 µg)
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terial cells were diluted in MH to make 1×106 CFU/
mL. Then, 1 mL of the suspensions were incubated 
with three concentrations of crude extract containing all 
PL-proteins (1/2×MIC, 1×MIC, 2×MIC) at 37°C for 1 
h and then filtered through a 0.22 µm filter membrane. 
As a positive control we used 3.4 mM EDTA. Filtrate 
absorbance at 260 nm was measured by Thermo Helios 
Omega UV-Vis Spectrophotometer.
DNA and RNA extraction from E. coli. DNA ex-
traction: from an overnight liquid culture of 100 mL 
E. coli (ATCC 8739) in MH, the bacterial cells were 
collected by centrifugation for 2 minutes at 14 000×g at 
4°C. The cells were suspended in 1 mL of lysis solution 
(10 mM Tris-HCl pH 8, 100 mM NaCl, 2%SDS, 10 mM 
EDTA pH 8, 20 μg/mL Proteinase K) and incubated 
for 30 minutes at 56°C. The DNA was purified by phe-
nol-chloroform extraction. At the end, the sample was 
resuspended in ddH2O and quantified using Nanodrop 
(NanoDrop 1000 ThermoScientific).
RNA extraction: SV Total RNA Isolation System 
(Promega) was used for RNA extraction from E. coli 
(ATCC 8739) following the manufacturer’s protocol for 
Gram-negative bacteria.
Analysis of the effect of M. galloprovincialis 
PL-proteins on E. coli DNA and RNA electropho-
retic mobility. The effect of M. galloprovincialis PL-pro-
teins on E. coli DNA and RNA was evaluated by Elec-
trophoretic Mobility Shift Assay (EMSA and REMSA 
respectively) on 1% and 1.5% agarose gels, respectively, 
using 300 ng of the specific nucleic acid and increasing 
amounts of crude extract containing all PL-proteins, ex-
pressed as protein/nucleic acid w/w ratios. M. galloprovin-
cialis PL-proteins were added to 300 ng of E. coli DNA 
or RNA in a final volume of 20 µL containing 1x TBE. 
After incubation for 10 minutes at room temperature, 
each mixture was analyzed on an agarose gel in TBE, as 
described by Carbone and others (Carbone et al., 2012). 
DNA or RNA migration was visualized by staining slab 
gels with ethidium bromide (2 µg/mL) after electropho-
resis. Protein to DNA ratios (w/w) are indicated on the 
wells of the gels.
Red blood cell lysis assay. The effects of Mytilus 
galloprovincialis crude extract containing PL-proteins was 
analyzed on isolated human red blood cells (RBCs) to 
evaluate their toxicity. We placed 1×106 erythrocytes in 
500 µL of 150 mM NaCl containing proteins at differ-
ent concentrations that have shown bactericidal activity, 
in order to evaluate the possible RBC lysis. We pre-
pared two control samples: one with 1×106 erythrocytes 
in 500 µL of physiological solution (ctr) containing 150 
mM NaCl without PL-proteins and the other with 1×106 
erythrocytes in 500 µL of distilled water, without PL- 
proteins, which was used to obtain total RBCs lysis. The 
erythrocytes were incubated with PL-proteins for 24 h 
at 4°C and the assay was performed in triplicate. The 
lysis of RBCs was monitored by the release of hemoglo-
bin. After removing the intact RBCs by centrifugation, 
we determined the spectrophotometric hemoglobin (Hb) 
absorbance at 415 nm, contained in the supernatant, and 
we obtained the number of lysed RBCs considering Hb 
ε mM=131 at this wavelength and that one RBC con-
tains about 32 picograms of Hb. The percentage of lysed 
RBCs after treatment with different amounts of PL-pro-
teins was obtained by the ratio between the values of 
absorbance at 415 nm of PL-proteins treated and that in 
which total lysis occurred with dH20 which was indicated 
as 100%.
Cell viability assay. The cytotoxicity of crude ex-
tract containing PL-proteins on human lymphocytes was 
measured using the 3-(4,5-dimethylthiazol-2yl)-2,5-di-
phenyl tetrazolium bromide (MTT) assay in agreement 
with the manufacturer’s instructions (MTT Cell Viability 
Assay Kit; Biotum, Inc) (Liu et al., 1997). Cells (1×106 
cells/well) in 420 μL of RPMI 1640 were seeded into 
two 24-well microtiter plates at 37°C and treated with 
PL-proteins (15.7–250 μg/mL) for 24 h. At the end of 
the exposure, 40 μL of 5 mg/mL MTT was added to 
each well and incubated for 2 h at 37°C, and then the 
water-insoluble formazan blue crystals generated were 
dissolved in 500 μL of dimethylsulfoxide (DMSO; Sig-
ma-Aldrich, Saint Quentin Fallavier, France) by pipet-
ting up and down several times and shaking for 15 min 
on an orbital shaker at 20°C. The samples were read at 
570 nm and 630 nm (background) to obtain cell viabil-
ity % (optical density, OD570–OD630). The percentage of 
cell viability was calculated by the following formula: 
[OD(570 nm) – OD(630 nm) treated/ OD(570 nm) – 
OD(630 nm) untreated] × 100% (Oliveira et al., 2013). 
All experiments were performed in triplicate, and the 
relative cell viability (%) was expressed as a percent-
age relative to the untreated control cells (ctr), i.e. cells 
treated with RPMI 1640 medium only. The cell prolif-
eration of ctr was indicated as 100%.
In vitro model of gastrointestinal digestion of 
the crude extract of PL-proteins. The assay was per-
formed according to the procedure described in (Raiola 
et al., 2012) with slight modification. GI digestion was 
distinguished into salivary, gastric and duodenal digestive 
steps. For the salivary digestion, the extract samples (20 
mg) were mixed with 6 mL of artificial saliva composed 
of: KCl (89.6 g/L), KSCN (20 g/L), NaH2PO4 (88.8 
g/L), Na2SO4 (57.0 g/L), NaCl (175.3 g/L), NaHCO3 
(84.7 g/L), urea (25.0 g/L) and 290 mg of α-amylase. 
The pH of the solution was adjusted to 6.8 with 0.1 N 
HCl. The mixture was introduced in a plastic bag con-
taining 40 mL of water and homogenized in a Stom-
acher 80 Microbiomaster (Seward, Worthing, UK) for 3 
min. Immediately, 0.5 g of pepsin (14 800 U) dissolved 
in 0.1 N HCl was added, the pH was adjusted to 2.0 
with 6 N HCl, and then incubated at 37°C in a Polymax 
1040 orbital shaker (250 rpm) (Heidolph, Schwabach, 
Germany) for 2 h. After the gastric digestion, the pan-
creatic digestion was simulated as follows: the pH was 
increased to 6.5 with 0.5 N NaHCO3 and then 5 mL 
of a mixture of pancreatin (8.0 mg/mL) and bile salts 
(50.0 mg/mL) (1:1; v/v) dissolved in 20 mL of water 
was added and incubated at 37°C in an orbital shaker 
(250 rpm) for 2 h. The intestinal digest was freeze-dried 
and then extracted with acetonitrile:water (84:16; v/v) 
mixture. The supernatant was evaporated to dryness and 
then stored at –20°C.
Statistical analysis. Multiple group data were ana-
lyzed using one-way ANOVA. The Student’s t-test was 
used to compare means between the groups. Values 
were considered significant when p<0.05. Statistically sig-
nificant differences are defined at the 95% confidence 
interval. Data are shown as mean ± S.D.
RESULTS
Isolation and analysis of PL-proteins from 
M. galloprovincialis
Before evaluation of the bactericidal activity, both 
crude extract and the single purified PL-proteins of 
M galloprovincialis were analyzed by AU-PAGE.
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Individually purified PL-II and PL-III are shown in 
Fig. 1A, while PL-IV in Fig. 1B in comparison with the 
crude extract which contained the three M. galloprovincialis 
PL-proteins. The percentage of PL-proteins evaluated of 
the overall nuclear proteins is in accordance with those 
shown by Lewis and Ausió (Lewis & Ausió, 2002).
Evaluation of bactericidal activity of M. galloprovincialis 
PL-proteins
Both the crude extract, as well as the individually 
purified PL-proteins of M. galloprovincialis, were tested 
for evaluation of their bactericidal activity. For this 
aim, MIC and MBC assays on Gram-positive and 
Gram-negative bacteria and on clinical isolates (CIs) 
of some bacterial strains were performed. All bac-
teria strains were inhibited by the tested molecules, 
with different MIC values as shown in Table 1. PL-
proteins had MIC values ranging from 7.8 to 250 µg/
mL. In order to investigate if these molecules could 
not only inhibit bacterial growth but also induce bac-
terial death, the cultures were plated on non-inhibito-
ry solid media and incubated for 24 h to evaluate the 
MBC values. All molecules showed bactericidal effects 
Table 2. Evaluation of bactericidal activity of M. galloprovincialis PL-proteins
MBC μg/mL MBC μg/mL MBC μg/mL MBC μg/mL
 Bacterial strains CRUDE EXTRACT PLII PLIII PIV
S. aureus ATCC 6738 62.5± 0.2 62.5±0.2 125±0.4 250±0.5
S. aureus ATCC 13709 31.3±0.1 31.3±0.1 62.5±0.2 62.5±0.3
S. aureus CI 62.5±0.3 62.5±0.2 62.5±0.3 125±0.4
E. faecalis ATCC 14428 62.5±0.2 125±0.3 125±0.3 125±0.4
E. faecalis CI 125±0.3 125±0.4 250±0.5 250±0.5
P. vulgaris ATCC 12454 62.5±0.3 62.5±0.3 125±0.5 125±0.5
P. vulgaris CI 125±0.5 250±0.5 250±0.4 250±0.3
P. mirabilis ATCC 7002 250±0.5 62.5±0.3 125±0.5 125±0.3
S. typhi ATCC 19430 15.7±0.2 15.7±0.2 62.5±0.3 62.5±0.2
S. typhi CI 31.3±0.2 31.3±0.3 62.5±0.3 125±0.4
E. cloacae ATCC 10699 31.3±0.1 31.3±0.1 125±0.3 125±0.3
E. cloacae CI 62.5±0.3 62.5±0.3 250±0.5 250±0.5
E. aerogenes ATCC 13048 250±0.5 250±0.5 250±0.5 250±0.5
E. aerogenes CI 250±0.5 250±0.5 250±0.4 250±0.4
P. aeruginosa ATCC 27853 31.3±0.2 62.5±0.3 250±0.4 250±0.4
P. aeruginosa CI 125±0.4 250±0.5 250±0.5 250±0.5
E. coli ATCC 8739 125±0.4 125±0.4 125±0.4 250±0.4
Minimum Bactericidal Concentration (MBC) values (µg/mL) of the crude extract containing the three PL-proteins and those of the purified PL-II, PL-
III, and PL-IV for bacterial strains analyzed. CI, Clinically Isolated. Values represent mean ± S.D. (n=3).
Figure 2. Impact of PL-proteins on RBCs lysis
(A) the percent human RBCs lysed after treatment. The histogram annotated with dH2O represents the total lysis (100%) of RBCs ob-
tained by placing RBCs in distilled water, while the other histograms represent the percentage of lysed cells in physiological solution 
alone (ctr) and in this solution with the addition of increasing amounts of PL-proteins expressed as µg/mL. (B) the same results as in A 
without the histogram relative to total lysis for better data visualization. Values represent mean ± S.D. (n=3). Asterisk indicates a statisti-
cally significant difference (P<0.05) when compared to control.
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with MBC values ranging from 15.7 to 250 µg/mL, as 
shown in Table 2, and were active against Gram-pos-
itive and Gram-negative species. The most sensitive 
bacterial strains were found to be Salmonella typhi and 
its CI, Staphylococcus aureus (ATCC 13709) and Entero-
bacter cloacae (ATCC 10699). The less sensitive bacteria 
strains were Proteus mirabilis (ATCC 7002) and Entero-
bacter aerogenes (ATCC 13048). Generally, CIs proved 
to be more resistant to PL-proteins than their stand-
ard strain counterparts.
Impact of PL-proteins on viability of human cells
In order to assess the impact of PL-proteins on vi-
ability of human cells, we performed RBC lysis and 
MTT assays. The results show that, in the presence of 
all PL-protein concentrations, the percentage of lysed 
cells is much lower than that obtained in distilled wa-
ter (indicated as 100%) and is not much higher with 
respect to that obtained in the presence of physiologi-
cal solution alone (ctr). In particular, the maximum 
percentage of lysed cells after incubation with PL-pro-
teins was about 2, as shown in Fig. 2B.
MTT assays performed on lymphocytes treated for 
24 h with the same amounts of crude extract contain-
ing PL-proteins indicated that cell viability was at least 
80–90% (Fig. 3).
Localization of PL-proteins in bacterial cells
The purpose of this section is to establish the ac-
tion site of PL-proteins in the bacterial cell. To 
achieve this goal, we performed fluorescence micros-
copy observations using DEAC,SE -PL-protein con-
jugate. The result showed that DEAC,SE-PL-protein 
conjugates added both, to S. aureus (ATCC 6738) and 
E. coli (ATCC 8739) inocula at a sub lethal concentra-
tion, produced a uniform distribution of fluorescence 
on the cell surface and even inside the cell (Figs. 4D 
and C, respectively). In fact, the images appeared sim-
ilar to the results obtained by staining the same bac-
teria with DAPI which enters cells and binds DNA 
(Figs. 4B and A, respectively). Experiments performed 
Figure 3. Impact of PL-proteins on cell viability.
Percent human lymphocyte viability after treatment with PL-pro-
teins by MTT assays. ctr refers to control cells that were only treat-
ed with the RPMI 1640 medium and their % viability was indicat-
ed as 100. Values represent mean ± S.D. (n=3). Asterisk indicates 
a statistically significant difference (P<0.05) when compared to 
control.
Figure 4. Localization of PL-proteins in bacterial cells.
Fluorescence microscopic observation of E. coli (ATCC 8739) 
(C) and S. aureus (ATCC 6738) (D) cells treated with DEAC,SE-
PL-protein conjugate. Panels A and B show E. coli (ATCC 8739) 
and S. aureus (ATCC 6738) cells, respectively, stained with DAPI. 
Merged image of DEAC,SE and DAPI-stained E. coli (ATCC 8739) (E) 
and S. aureus (ATCC 6738) (F) cells. Magnification: 400x; scale bars, 
5 μm.
Figure 5. Analysis of the effect of M. galloprovincialis PL-pro-
teins’ binding on E. coli nucleic acids’ mobility
EMSA (A) and REMSA (B) analyzed on 1% and 1.5% agarose gels, 
respectively, performed with E. coli (ATCC 8739) DNA(A) and RNA 
(B), and increasing amounts of M. galloprovincialis PL-proteins. The 
numbers indicated on the wells indicate the PL-proteins/nucleic 
acid (w/w) ratios. The samples indicated with DNA and RNA cor-
respond to the nucleic acid alone.
Figure 6. Cell nucleotide leakage induced by PL-proteins
Cell nucleotide leakage by treating E. coli (ATCC 8739) (A) and S. aureus (ATCC 6738) (B) with PL-proteins. EDTA was used as a positive 
control. Data are expressed as mean ± S.D. Asterisk indicates a statistically significant difference (P<0.05) when compared to control.
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with DEAC,SE-free dye (non-conjugated), used as 
controls (data not shown), indicate that the dye was 
not taken up by the cells in the absence of PL-pro-
teins. Merged images are also shown of DEAC,SE 
and DAPI stained E. coli (ATCC 8739) (Fig. 4E) and 
S. aureus (ATCC 6738) (Fig. 4F).
Analysis of the effect of M. galloprovincialis PL-proteins 
binding on E. coli nucleic acids mobility
To evaluate the possible interaction of PL-proteins 
with some internal cellular targets, such as bacterial 
nucleic acids, we tested PL-proteins in EMSA and 
REMSA experiments using E. coli (ATCC 8739) DNA 
and RNA, respectively. The results suggested that PL-
proteins have affinity for both bacterial nucleic acids. 
In fact, the saturation of nucleic acids, i.e. when all 
the nucleic acid bands are observed near the origin of 
migration, is achieved at a PL/nucleic acid ratio 4 for 
RNA and 12 in the case of DNA (Fig. 5).
Nucleotide leakage induced by PL-proteins
In order to also investigate the possibility of action 
of PL-proteins at a membrane level, we performed 
experiments to check the nucleotide leakage from 
bacterial cells after treatment with the same PL-pro-
tein amounts which have shown bactericidal effects. 
The experiments were conducted on S. aureus (ATCC 
6738) and E. coli (ATCC 8739) using 3.4 mM EDTA 
as a positive control. The results demonstrated that 
there was nucleotide leakage, particularly from S. au-
reus cells (Fig. 6).
Analysis and bactericidal activity of the in vitro 
gastrointestinal digestion product of PL-proteins
To assess whether bactericidal activity of PL-pro-
teins was maintained even after gastrointestinal diges-
tion, we performed the in vitro model of gastrointes-
tinal digestion of PL-proteins; analyzed the digest by 
SDS-PAGE and determined MIC and MBC values for 
S. aureus (ATCC 6738) and E. coli (ATCC 8739). SDS-
PAGE analysis shows that the digest resulted in PL-
IV plus a mixture of peptides. The digest, compared 
to the undigested PL-proteins, presents the same bac-
tericidal activity against Staphylococcus aureus but lower 
activity against Escherichia coli, as shown by MIC and 
MBC values (Table 3).
DISCUSSION
The growing number of bacteria resistant to conven-
tional antibiotics has become a grave medical problem 
that has generated extensive interest in the use of ‘natu-
ral’ alternatives. Although terrestrial biodiversity has been 
the base of the pharmaceutical industry, the oceans have 
colossal biodiversity and potential to provide novel com-
pounds with commercial value (Smit, 2004; El-Gamal 
et al., 2013). This is because marine invertebrates, living 
within very difficult, competitive, and hostile surround-
ings represent a great reservoir for compounds with 
improved bactericidal activity. Mytilus galloprovincialis is 
an excellent bioindicator and bioaccumulator of marine 
pollution (Piscopo et al., 2016) and as we have recently 
shown, it has altered levels of hsp70 in spermatozoa, go-
nadal and gill tissues (Piscopo et al., 2018c; Piscopo et 
al., 2017) and demonstrates changes in sperm protamine-
like protein properties (Piscopo et al., 2018b, Piscopo et 
al., 2018c), as a response to environmental stress/geo-
graphical site of this organism. The first work concern-
ing bactericidal activity identified in mollusks was relative 
to the mucus of the giant snail Achatina fulica (Kubota 
et al., 1985). Afterwards, bacteriostatic proteins were 
also discovered in the sea hares Aplysia kurodai and Do-
labella auricularia (Kamiya et al., 1986; Iijima et al., 2003) 
and in 1996, true antimicrobial peptides were isolated 
from M. galloprovincialis (Hubert et al., 1996) and M. edulis 
(Charlet et al., 1996). Given that nothing has been shown 
in the literature about the bactericidal activity of PL-pro-
teins, which are sperm proteins that are different from 
the histone (H) and protamine (P) types, we investigated 
the bactericidal activity of M. galloprovincialis PL-proteins. 
The primary structure of the Mytilus PL-proteins is 
shown in Carlos and others (Carlos et al., 1993a) and in 
Rocchini and others (Rocchini et al., 1995).
PL-proteins were extracted from spermatozoa, puri-
fied and analyzed by AU-PAGE.
PL-II and PL-III appeared as a highly pure single 
band (Fig. 1A lanes 4 and 5 and Fig. 1A lanes 6 and 
7, respectively). In contrast, several subcomponents were 
present in the region of the gel corresponding to PL-IV 
(Fig. 1B lanes 1 and 2) and reflect the microheteroge-
Figure 7. Analysis of the product of in vitro model of gastroin-
testinal digestion of M. galloprovincialis PL-proteins
Lanes 1 and 2: (digest, 20 and 10 µg, respectively) analyzed by 
SDS-PAGE in comparison with the undigested PL-proteins (lane 3)
Table 3. Evaluation of bacteriostatic and bactericidal activities of the product obtained from in vitro model of gastrointestinal diges-
tion of protamine-like proteins
MIC MBC MIC MBC
Bacterial strains DIGEST DIGEST CRUDE  EXTRACT CRUDE EXTRACT 
S. aureus ATCC 6738 31.3±0.2 62.5±0.2 31.3±0.0 62.5±0.2
E. coli ATCC 8739 125±0.3 250±0.5 62.5±0.3 125±0.4 
Comparison between MIC and MBC values (µg/mL) of the digest and the crude extract containing the three M. galloprovincialis PL-proteins ob-
tained for Gram-positive, Staphylococcus aureus (ATCC 6738) and Gram-negative E. coli (ATCC 8739) bacteria. MIC and MBC values (µg/mL) represent 
mean ± S.D. (n=3).
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rial cells by Rezansoff and others (Rezansoff et al., 2005). 
It will be necessary to prove PL-protein action on bac-
terial membranes in future experiments, such as assays 
involving fractionation of membranes. Since PL-proteins 
also enter bacterial cells, it cannot be excluded that the 
mechanism of their action could depend on their inter-
action with an intracellular component. Indeed, since the 
natural function of PL-proteins is to bind nucleic acids, 
it is reasonable to suggest that they could affect some 
cellular processes, such as replication, transcription or 
translation, in the target cells. Such an effect has been 
previously shown for indolicidin, a proline and arginine 
rich antimicrobial peptide isolated from cytoplasmic 
granules of bovine neutrophils, which inhibits DNA syn-
thesis (Subbalakshmi and Sitaram,1998). After all, the re-
sults of our EMSA and REMSA experiments confirmed 
that PL-proteins had affinity for bacterial nucleic acids 
(Fig. 5). However, since different size nucleic acid par-
ticles were used in these assays, we cannot establish for 
which nucleic acids the PL-proteins have higher affinity.
Antibacterial proteins have a potential as alternative treat-
ments to standard antibiotic therapies and therefore it is 
important to define if there are issues with delivery of these 
agents inside the body. Oral administration would most 
likely result in the proteins being degraded in the digestive 
system. In order to analyze this aspect we generated an in 
vitro model of gastrointestinal digestion of PL-proteins. The 
digest included PL-IV together with a mixture of peptides 
probably deriving from PL-II and PL-III, and were tested 
on S. aureus (ATCC 6738) and E. coli (ATCC 8739) which 
were used as Gram-positive and Gram-negative represen-
tatives, respectively. The digest showed the same bacteri-
cidal activity against Staphylococcus aureus, but was lower for 
Escherichia coli when compared to undigested proteins. Ob-
viously, the influence of these proteins on the human di-
gestive tract microbiome should be investigated in future 
studies. In conclusion, this work presents the first evidence 
obtained for Mytilus galloprovincialis of bactericidal activity 
of the PL-proteins. The discovery of antibiotics with nov-
el mechanisms of action is a critical issue to overcome the 
serious problem of growing numbers of bacteria resistant 
to conventional antibiotics (Lohner & Staudegger, 2001). 
Therefore it would be interesting to further understand the 
mechanism of action of these proteins and their effective 
targets in order to use them as bactericidal agents. Further 
experiments will be also required to better analyze the bac-
tericidal activity of digested PL-proteins against other bacte-
rial strains. We cannot exclude that bacteria could become 
resistant to these proteins in the environment but further 
experiments will be necessary to address this which could 
be the focus of our future studies.
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neity of this protein, as previously described by Ausió 
and Subirana (Ausió & Subirana, 1982), similar to what 
is observed in protamines (Ausió et al., 1989). Such mi-
crohereterogeneity in PL-IV is also due to the fact that 
8% of its serines are phosphorylated (Ausió & Subira-
na, 1982). Both, the crude extract containing the three 
PL-proteins and the singularly purified PL-II, PL-III and 
PL-IV were used to test their bactericidal activity against 
several Gram-positive and Gram-negative bacteria. Both, 
the crude extract and the individual PL-proteins, yield-
ed bactericidal activity against all the strains tested. The 
MBC values for almost all bacterial strains showed that 
the crude extract containing the three PL-proteins was 
more efficient for only 4 out of 16 strains, and partic-
ularly for Enterococcus faecalis (ATCC 14428), Proteus vul-
garis (CI), and Pseudomonas aeruginosa (ATCC 27853) and 
its CI. The MBC of crude extract was found to have an 
efficiency similar to PL-II for 8 out of 16 tested strains 
and particularly in Staphylococcus aureus (ATCC 13709 
and ATCC 6738), Enterococcus faecalis (CI), Proteus vulgaris 
(ATCC 12454), Salmonella typhi (ATCC 19430) and its CI, 
and Enterobacter cloacae (ATCC 10699) and its CI. Taken 
together, PLII proved to be the most efficient inhibi-
tory protein. In other cases, the MBC of crude extract 
was the same as the rest of pure proteins. PL-proteins 
turned out to be active not only against all tested bacte-
rial strains but surprisingly also against some strains that 
are generally resistant to conventional antibiotics, such as 
S. aureus CI, E. faecalis CI, P. vulgaris CI, E. cloacae ATCC 
10699, E. cloacae CI, E. aerogenes ATCC 13048, E. aerogenes 
CI, and P. aeruginosa CI. RBC lysis and viability MTT as-
says were performed on human RBC and lymphocytes, 
respectively, treated with PL-proteins at the concentra-
tions that produced bactericidal activity. After 24 h treat-
ment with PL-proteins, lymphocyte viability was at least 
80%, while a maximum RBC lysis of only 2% was ob-
served. Given the very low toxicity of these proteins at 
the concentrations which produced bactericidal activity, 
for their possible therapeutic use, we investigated their 
site of action in the bacterial cell. In order to evaluate 
whether PL-proteins enter the bacteria or act at the cell 
surface, S. aureus (ATCC 6738) and E. coli (ATCC 8739) 
were incubated in the presence of DEAC,SE-PL-protein 
conjugate and a uniform distribution of fluorescence was 
observed on the cell surface, as well as inside the cell. 
These results are in agreement with those shown in the 
literature on other basic molecules (Mitchell et al., 2000; 
Conte et al., 2007). The molecules with bactericidal activ-
ity are mainly positively charged peptides and by virtue 
of their hydrophobic and hydrophilic sides are able to be 
soluble in aqueous environments and also to enter lip-
id-rich membranes (Izadpanah & Gallo, 2005). Our re-
sults, obtained by fluorescence microscopy, indicate that 
PL-proteins could depolarize the bacterial cytoplasmic 
membrane and cause cell lysis, as shown for protamines 
(Pink et al., 2014), or enter the cells for possible interac-
tion with some intracellular target (Zasloff, 2002). The 
results of our nucleotide leakage assay (Fig. 6) showed 
that after treatment with PL-proteins for both bacteria, 
the nucleotide leakage was observed. This was particu-
larly noticeable for S. aureus cells for which the amount 
of leaked nucleotides increased in a dose dependent 
manner. We used 3.4 mM EDTA as a positive control. 
EDTA is a metal chelator that removes metal cations 
in the cell wall causing nucleotide leakage from the cell 
(Gray & Wilkinson, 1965). Based on these data, PL-pro-
teins could be acting at the bacterial membrane level, as 
previously shown for the Ac-FRWWHR-NH2 antimicro-
bial peptide with a model membrane systems and bacte-
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